Market Currents
Quest Diagnostics (DGX +4.3%) surges, thanks to a 1996 deal with Merck over osteoporosis drug...
-
Thursday, July 12, 2012, 3:24 PM ETQuest Diagnostics (DGX +4.3%) surges, thanks to a 1996 deal with Merck over osteoporosis drug odanacatib, which may pay off to the tune of $75M. (earlier: success of odanacatib)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
